SHH and basal cell carcinoma: Indeed, a recent study showed that smoothened inhibitor-resistant basal cell carcinomas exhibit MAPK pathway enrichment concomitant with increases in ciliome gene mutations and reductions in primary cilia [47] suggesting that the primary cilia control SHH-to-MAPK pathway switching.